Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2020

Aug 12, 2020

30150_dirs_2020-08-12_ff02b5da-03d4-4977-a191-a15a66872cd1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-05-15

Reporting Person: SORIANO JOHN (Chief Compliance Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-15 Common Stock F 994 $25.46 Disposed 78253 Direct
2020-08-10 Common Stock M 52046 $13.91 Acquired 77259 Direct
2020-08-10 Common Stock S 52046 $30.29 Disposed 25213 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-10 Stock Option (right to buy) $13.91 M 52046 Disposed 2029-01-03 Common Stock (52046) Direct

Footnotes

F1: Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error.

F2: This is the weighted average sales price representing 52,046 shares sold at prices ranging from $30.12 to $30.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.